CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Int J Gynaecol Obstet
; 48(2): 187-92, 1995 Feb.
Article
em En
| MEDLINE
| ID: mdl-7540567
ABSTRACT
OBJECTIVE:
To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease.METHODS:
The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women with macrocysts.RESULTS:
Significantly higher levels of CA 125, CA 27.29, beta-hCG and CEA were observed in the cyst fluid than in the serum of the same patients. According to their K+/Na+ quotient we found that when K+/Na+ was < 3, cyst fluid CA 125, CA 27.29, beta-hCG and CEA levels were significantly higher than serum levels. However, when K+/Na+ was > 3, only CA 27.29 and beta-hCG levels were significantly higher. Comparing cyst fluid marker levels with respect to the K+/Na+ ratio, the only difference observed was in CA 125 which was significantly greater when K+/Na+ was < 3. A negative correlation was found between CA 125 and the K+/Na+ quotient.CONCLUSION:
These results suggest that CA 125 could be used as a marker to identify cyst type.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fragmentos de Peptídeos
/
Antígenos Glicosídicos Associados a Tumores
/
Alfa-Fetoproteínas
/
Antígeno Carcinoembrionário
/
Biomarcadores Tumorais
/
Mucina-1
/
Antígeno Ca-125
/
Doença da Mama Fibrocística
/
Gonadotropina Coriônica
/
Antígenos de Neoplasias
Tipo de estudo:
Diagnostic_studies
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Int J Gynaecol Obstet
Ano de publicação:
1995
Tipo de documento:
Article